These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8384824)

  • 1. The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats.
    Wyde PR; Ambrose MW; Meyerson LR; Gilbert BE
    Antiviral Res; 1993 Feb; 20(2):145-54. PubMed ID: 8384824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
    Wyde PR; Ambrose MW; Meyer HL; Zolinski CL; Gilbert BE
    Antiviral Res; 1990; 14(4-5):215-25. PubMed ID: 1965109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
    Wyde PR; Ambrose MW; Meyer HL; Gilbert BE
    Antiviral Res; 1990; 14(4-5):237-47. PubMed ID: 1965110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Pimentel DM; Blough HA
    Antiviral Res; 1995 May; 27(1-2):59-69. PubMed ID: 7486959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303.
    Barnard DL; Huffman JH; Meyerson LR; Sidwell RW
    Chemotherapy; 1993; 39(3):212-7. PubMed ID: 8508691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats.
    Gilbert BE; Wyde PR; Wilson SZ; Meyerson LR
    Antiviral Res; 1993 May; 21(1):37-45. PubMed ID: 8317921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.
    Gruber WC; Wilson SZ; Throop BJ; Wyde PR
    Pediatr Res; 1987 Mar; 21(3):270-4. PubMed ID: 3550674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
    Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
    Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection.
    Wyde PR; Chetty SN; Timmerman P; Gilbert BE; Andries K
    Antiviral Res; 2003 Nov; 60(3):221-31. PubMed ID: 14638398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.
    Garg R; Latimer L; Gomis S; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Antiviral Res; 2019 Feb; 162():54-60. PubMed ID: 30550799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats.
    Gilbert BE; Wyde PR; Ambrose MW; Wilson SZ; Knight V
    Antiviral Res; 1992 Jan; 17(1):33-42. PubMed ID: 1736809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.
    Murphy BR; Prince GA; Collins PL; Van Wyke Coelingh K; Olmsted RA; Spriggs MK; Parrott RH; Kim HW; Brandt CD; Chanock RM
    Virus Res; 1988 Aug; 11(1):1-15. PubMed ID: 2845680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
    Jones B; Zhan X; Mishin V; Slobod KS; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2009 Mar; 27(12):1848-57. PubMed ID: 19200447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of the campaign against acute respiratory viral diseases in children].
    Pringle CR
    Bull World Health Organ; 1987; 65(4):435-9. PubMed ID: 2826029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.